NCT06807307View on ClinicalTrials.gov

Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential

RecruitingOBSERVATIONAL
Enrollment

256

Participants

Timeline

Start Date

June 4, 2024

Primary Completion Date

June 4, 2026

Study Completion Date

June 4, 2026

Conditions
NSCLC
Trial Locations (1)

00144

RECRUITING

"IRCCS National Cancer Institute Regina Elena", Rome

All Listed Sponsors
lead

Regina Elena Cancer Institute

OTHER